Jain, P., Surrey, L., Straka, J., Luo, M., Resnick, A. C., Storm, P. B., . . . Waanders, A. J. (2018). LGG-25. NOVEL FGFR2 FUSIONS DRIVE ONCOGENESIS VIA MAPK AND PI3K/mTOR PATHWAY ACTIVATION IN DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMORS. Neuro Oncol.
Chicago Style CitationJain, Payal, Lea Surrey, Joshua Straka, Minjie Luo, Adam C. Resnick, Phillip B. Storm, Mariarita Santi, Marilyn Li, i Angela J. Waanders. "LGG-25. NOVEL FGFR2 FUSIONS DRIVE ONCOGENESIS VIA MAPK AND PI3K/mTOR PATHWAY ACTIVATION IN DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMORS." Neuro Oncol 2018.
Cita MLAJain, Payal, et al. "LGG-25. NOVEL FGFR2 FUSIONS DRIVE ONCOGENESIS VIA MAPK AND PI3K/mTOR PATHWAY ACTIVATION IN DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMORS." Neuro Oncol 2018.
Atenció: Aquestes cites poden no estar 100% correctes.